Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
GAS7 overexpression
Cancer:
Hepatocellular Cancer
Drug:
oxaliplatin
(
DNA synthesis inhibitor
,
DNA cross linking agent
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Acta Biochim Biophys Sin (Shanghai)
Title:
Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway
Published date:
05/05/2017
Excerpt:
Our results showed that oxaliplatin inhibited the proliferation and migration ability via GAS7C up-regulation and the N-WASP/FAK/F-actin pathway;…
DOI:
https://doi.org/10.1093/abbs/gmx046
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.